Bebbington, P., & Nayani, T. (1996). The psychosis screening questionnaire. International Journal of Methods in Psychiatric Research, 5(1), 11-19.
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213. https://doi.org/10.1016/0165-1781(89)90047-4.
Carey, K. B., Carey, M. P., & Chandra, P. S. (2003). Psychometric evaluation of the Alcohol Use Disorders Identification Test and short drug abuse screening test with psychiatric patients in India. The Journal of Clinical Psychiatry, 64(7), 767–774. https://doi.org/10.4088/jcp.v64n0705.
Einvik, G., Dammen, T., Ghanima, W., Heir, T., & Stavem, K. (2021). Prevalence and risk factors for post-traumatic stress in hospitalized and non-hospitalized COVID-19 patients. International Journal of Environmental Research and Public Health, 18(4), 2079. https://doi.org/10.3390/ijerph18042079.
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M.P., & Marks, J. S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The adverse childhood experiences (ACE) study. American Journal of Preventive Medicine, 14(4), 245–258. https://doi.org/10.1016/S0749-3797(98)00017-8.
Filchakova, O., Dossym, D., Ilyas, A., Kuanysheva, T., Abdizhamil, A., & Bukasov, R. (2022). Review of COVID-19 testing and diagnostic methods. Talanta, 244, 123409. https://doi.org/10.1016/j.talanta.2022.123409.
Haddock, G., McCarron, J., Tarrier, N., & Faragher, E.B. (1999). Scales to measure dimensions of hallucinations and delusions: The Psychotic Symptom Rating Scales (PSYRATS). Psychological Medicine, 29(4), 879-889. https://doi.org/10.1017/S0033291799008661.
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., Anheim, M., & Meziani, F. (2020). Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine, 328, 2268-2270. https://doi.org/10.1056/NEJMc2008597.
Hermens, M.L.M., Adèr, H.J., van Hout, H.P.J., Terluin, B., van Dyck, R., & de Haan, M. (2006). Administering the MADRS by telephone or face-to-face: A validity study. Annals of General Psychiatry, 5, 3. https://doi.org/10.1186/1744-859X-5-3.
Hsieh, S., McGrory, S., Leslie, F., Dawson, K., Ahmed, S., Butler, C. R., Rowe, J.B., Mioshi, E., & Hodges, J.R. (2015). The Mini-Addenbrooke’s Cognitive Examination: A new assessment tool for dementia. Dementia and Geriatric Cognitive Disorders, 39(1-2), 1-11. https://doi.org/10.1159/000366040.
Hughes, M.E., Waite, L.J., Hawkley, L.C., & Cacioppo, J.T. (2004). A short scale for measuring loneliness in large surveys. Research on Aging, 26(6), 655-672. https://doi.org/10.1177/0164027504268574.
Humeniuk, R., Ali, R., & WHO ASSIST Phase II Study Group. (2006). Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and pilot brief intervention. https://www.who.int/substance_abuse/activities/assist_technicalreport_phase2_final.pdf.
Jacot de Alcântara, I., Nuber-Champier, A., Voruz, P., Cionca, A., Assal, F., & Péron, J.A. (2023). Cognitive deficits in the acute phase of COVID-19: A review and meta-Analysis. Journal of Clinical Medicine, 12, 762. https://doi.org/10.3390/jcm12030762.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P, & Busschbach, J. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727. https://doi.org/10.1007/s11136-012-0322-4.
Kocalevent, R.D., Berg, L., Beutel, M.E., Hinz, A., Zenger, M., Härter, M., Nater, U., & Brähler, E. (2018). Social support in the general population: Standardization of the Oslo social support scale (OSSS-3). BMC Psychology, 6, 31. https://doi.org/10.1186/s40359-018-0249-9.
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046%2Fj.1525-1497.2001.016009606.x.
Matza, L.S., Morlock, R., Sexton, C., Malley, K., & Feltner, D. (2010). Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. International Journal of Methods in Psychiatric Research, 19(4), 223-232. https://doi.org/10.1002/mpr.323.
Menachemi, N., Dixon, B.E., Wools-Kaloustian, K.K., Yiannoutsos, C.T., & Halverson, P.K. (2021). How many SARS-CoV-2-infected people require hospitalization? Using random sample testing to better inform preparedness efforts. Journal of Public Health Management and Practice, 27(Suppl 1), S45-S49. https://doi.org/10.1097/PHH.0000000000001331.
Miranda, D.D.C., Brucki, S.M.D., & Yassuda, M.S. (2018). The Mini-Addenbrooke’s Cognitive Examination (M-ACE) as a brief cognitive screening instrument in mild cognitive impairment and mild Alzheimer’s disease. Dementia & Neuropsychologia, 12(4), 341-347. https://doi.org/10.1590/1980-57642018dn12-040005.
Michielsen, H. J., De Vries, J., & Van Heck, G. L. (2003). Psychometric qualities of a brief self-rated fatigue measure. Journal of Psychosomatic Research, 54(4), 345–352. https://doi.org/10.1016/s0022-3999(02)00392-6.
Müller, M.J., Himmerich, H., Kienzle, B., & Szegedi, A. (2003). Differentiating moderate and severe depression using the Montgomery-Åsberg Depression Rating Scale (MADRS). Journal of Affective Disorders, 77(3), 255-260. https://doi.org/10.1016/S0165-0327(02)00120-9.
Nersesjan, V., Fonsmark, L., Christensen, R. H. B., Amiri, M., Merie, C., Lebech, A. M., Katzenstein, T., Bang, L. E., Kjærgard, J., Kondziella, D., & Benros, M. (2022). Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for Non–COVID-19 illness. JAMA Psychiatry, 79(5), 486–497. https://doi.org/10.1001/jamapsychiatry.2022.0284.
Ottawa Public Health. (2022). Case demographics. Ottawa’s COVID-19 dashboard. https://www.ottawapublichealth.ca/en/reports-research-and-statistics/covid19-dashboard.aspx.
Osler, W. (1892). Principles and practice of medicine (1st ed.). D. Appleton and Company.
Prins, A., Bovin, M. J., Smolenski, D. J., Marx, B. P., Kimerling, R., Jenkins-Guarnieri, M. A., Kaloupek, D. G., Schnurr, P. P., Pless Kaiser, A., Leyva, Y.E., & Tiet, Q. Q. (2016). The Primary Care PTSD screen for DSM-5 (PC-PTSD-5): Development and evaluation within a veteran primary care sample. Journal of General Internal Medicine, 31, 1206–1211. https://doi.org/10.1007/s11606-016-3703-5.
Renaud-Charest, O., Lui, L. M. W., Eskander, S., Ceban, F., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Lee, Y., Subramaniapillai, M., & McIntyre, R.S. (2021). Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. Journal of Psychiatric Research, 144, 129-137. https://doi.org/10.1016/j.jpsychires.2021.09.054.
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M.S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 7(7), 611-627. https://doi.org/10.1016/S2215-0366(20)30203-0.
Salerno, J. P., Williams, N. D., & Gattamorta, K. A. (2020). LGBTQ populations: Psychologically vulnerable communities in the COVID-19 pandemic. Psychological Trauma: Theory, Research, Practice, and Policy, 12(S1). https://doi.org/10.1037/tra0000837.
Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363–371. https://doi.org/10.1016/0306-4603(82)90005-3.
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092.
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021). 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), 416-427. https://doi.org/10.1016/S2215-0366(21)00084-5.
Tavares-Júnior, J. W. L., de Souza, A. C. C., Borges, J. W. P., Oliveira, D. N., Siqueira-Neto, J. I., Sobreira-Neto, M. A., & Braga-Neto, P. (2022). COVID-19 associated cognitive impairment: A systematic review. Cortex, 152, 77–97. https://doi.org/10.1016/j.cortex.2022.04.006.
Tennant, R., Hiller, L., Fishwick, R., Platt, S., Joseph, S., Weich, S., Parkinson, J., Secker, J., & Stewart-Brown, S. (2007). The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): Development and UK validation. Health Qual Life Outcomes, 5, 63. https://doi.org/10.1186/1477-7525-5-63.
The Columbia Lighthouse Project/Center for Suicide Risk Assessment. (2018). The Columbia Suicide Severity Rating Scale (C-SSRS): Supporting evidence. https://cssrs.columbia.edu/wp-content/uploads/CSSRS_Supporting-Evidence_Book_2023-05.pdf
United Nations. (2020). Policy Brief: The impact of COVID-19 on women. https://www.unwomen.org/sites/default/files/Headquarters/Attachments/Sections/Library/Publications/2020/Policy-brief-The-impact-of-COVID-19-on-women-en.pdf.
Van Ameringen, M., Mancini, C., Patterson, B., & Boyle, M. H. (2008). Post‐traumatic stress disorder in Canada. CNS Neuroscience & Therapeutics, 14(3), 171–181. https://doi.org/10.1111/j.1755-5949.2008.00049.x.
Vanderlind, W. M., Rabinovitz, B. B., Miao, I. Y., Oberlin, L. E., Bueno-Castellano, C., Fridman, C., Jaywant, A., & Kanellopoulos, D. (2021). A systematic review of neuropsychological and psychiatric sequelae of COVID-19: Implications for treatment. Current Opinion in Psychiatry, 34(4), 420–433. https://doi.org/10.1097%2FYCO.0000000000000713.
Velichkovsky, B., Razvaliaeva, A., Khlebnikova, A., Manukyan, P., Kasatkin, V., & Barmin, A. (2023). Systematic review and meta-analysis of clinically relevant executive functions test performance after COVID-19. Behavioral Neurology. https://doi.org/10.1155/2023/1094267/.
Von Elm E, Egger M, Altman DG, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. (2007). Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. British Medical Journal. 370(9596), 1453-1457. https://doi.org/10.1016/S0140-6736(07)61602-X.
Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486.
Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. (2007). Diagnostic accuracy of the mood module of the Patient Health Questionnaire: A systematic review. General Hospital Psychiatry, 29(5), 388–395. https://doi.org/10.1016/j.genhosppsych.2007.06.004.
World Health Organization. (2020). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. WHO Director – Speeches. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020#:~:text=WHO.
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine, 28(3), 583–590. https://doi.org/10.1038/s41591-022-01689-3.